Senators Mull Ways to Stop Patent 'Abuse' by Pharma Companies

[cafead]

via Senators and experts on Tuesday examined the range of tools that brand-name drug manufacturers have used to keep generic and biosimilar competition at bay -- from patent thickets and product hopping to "pay-for-delay" settlements -- and wrestled with how to prevent such abuses.

article source